WordNet

used to express refusal or denial or disagreement etc or especially to emphasize a negative statement; "no, you are wrong"
a negative; "his no was loud and clear"
referring to the degree to which a certain quality is present; "he was no heavier than a child" (同)no more
not in any degree or manner; not at all; "he is no better today"
quantifier; used with either mass nouns or plural count nouns for indicating a complete or almost complete lack or zero quantity of; "we have no bananas"; "no eggs left and no money to buy any"; "have you no decency?"; "did it with no help"; "Ill get you there in no time"
a harmful or corrupting agency; "bigotry is a virus that must not be allowed to spread"; "the virus of jealousy is latent in everyone"
(virology) ultramicroscopic infectious agent that replicates itself only within cells of living hosts; many are pathogenic; a piece of nucleic acid (DNA or RNA) wrapped in a thin coat of protein
a software program capable of reproducing itself and usually capable of causing great harm to files or other programs on the same computer; "a true virus cannot spread to another computer without human assistance" (同)computer virus
the 3rd letter of the Roman alphabet (同)c
(music) the keynote of the scale of C major
a general-purpose programing language closely associated with the UNIX operating system
the 2nd letter of the Roman alphabet (同)b
the blood group whose red cells carry the B antigen (同)type_B, group B
inflammation of the liver caused by a virus or a toxin

PrepTutorEJDIC

《名詞の前に置いて》『一つも』(『一人も,少しも』)・・・『ない』 / 《補語につけて》『決して・・・でない』 / 《省略文で》・・・なし;・・・お断り / 《話》少ししか(あまり)・・・ない / (肯定の問いに対して)『いいえ』;(否定の問いに対して)はい,ええ / 《not, norの前に挿入して》『いや』,否 / 《形容詞の前に置その形容詞を否定して》…どころではない / 《比較級の前に置いて》ちっとも…でない,…と全く同じ / 《… or no の形で》…であってもなくても / 《驚き・困惑・不信などを表して》とんでもない / 《単数形で》『拒否』,「『いいえ』」という返事 / 《複数形で》反対[投]票
ビールス,ろ過性病原体
carbonの化学記号
肝[臓]炎

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 慢性C型肝炎ウイルス感染のスクリーニングおよび診断 screening for and diagnosis of chronic hepatitis c virus infection
2. C型肝炎ウイルス感染の肝外症状 extrahepatic manifestations of hepatitis c virus infection
3. C型肝炎ウイルス感染に対する試験的治療 investigational therapies for hepatitis c virus infection
4. C型肝炎ウイルス感染の臨床症状および自然経過 clinical manifestations and natural history of hepatitis c virus infection
5. 遺伝子1型慢性C型肝炎ウイルスの治療におけるテラプレビルおよびボセプレビルの研究 studies of telaprevir and boceprevir in the treatment of chronic hepatitis c virus genotype 1

English Journal

Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: A pilot study.

Tanaka K, Yabushita Y, Nakagawa K, Kumamoto T, Matsuo K, Taguri M, Endo I.Author information Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. Electronic address: ktrj112@urahp.yokohama-cu.ac.jp.AbstractBACKGROUND: The prognosis in advanced hepatocellular carcinoma (HCC) with multiple intrahepatic metastases is extremely poor. Combination therapy with subcutaneous interferon (IFN) alfa and intraarterial 5-fluorouracil was reported to be effective against such advanced HCC. We describe results of debulking surgery followed by combination therapy with IFN alfa and 5-FU for massive HCC with multiple intrahepatic metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.Eur J Surg Oncol.2013 Dec;39(12):1364-70. doi: 10.1016/j.ejso.2013.10.007. Epub 2013 Oct 23.
BACKGROUND: The prognosis in advanced hepatocellular carcinoma (HCC) with multiple intrahepatic metastases is extremely poor. Combination therapy with subcutaneous interferon (IFN) alfa and intraarterial 5-fluorouracil was reported to be effective against such advanced HCC. We describe results of de
PMID 24183169

Non-B, non-C hepatocellular carcinoma (Review).

Nishikawa H, Osaki Y.Author information Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Tennoji-ku, Osaka 543-0027, Japan.AbstractAlthough most hepatocellular carcinoma (HCC) is related to viral infection, there is a substantial population of HCC patients (5-20%) who are negative for both markers of hepatitis B virus and hepatitis C virus infection [non-B, non-C (NBNC) hepatitis] in Japan and the incidence of NBNC-HCC has recently tended to increase. The most common cause of liver disease in developed countries is non‑alcoholic fatty liver disease (NAFLD), which includes non‑alcoholic steatohepatitis (NASH) and its related complications. Increased body mass index and diabetes mellitus are associated with developing NAFLD and NASH, which is a severe form of NAFLD. Furthermore, increasing clinical evidence supports the fact that NAFLD and NASH can progress to liver cirrhosis and even HCC. A detailed understanding of the epidemiology, etiology, molecular mechanism, clinical features and prognosis of NBNC-HCC could improve our screening and therapy of this disease. In this review, we primarily focus on clinical aspects of NBNC-HCC and refer to our current knowledge of this cancer.
International journal of oncology.Int J Oncol.2013 Nov;43(5):1333-42. doi: 10.3892/ijo.2013.2061. Epub 2013 Aug 20.
Although most hepatocellular carcinoma (HCC) is related to viral infection, there is a substantial population of HCC patients (5-20%) who are negative for both markers of hepatitis B virus and hepatitis C virus infection [non-B, non-C (NBNC) hepatitis] in Japan and the incidence of NBNC-HCC has rece
PMID 23969900

Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.

Kudo A, Tanaka S, Ban D, Matsumura S, Irie T, Ochiai T, Nakamura N, Arii S, Tanabe M.Author information Department of Hepatobiliary-Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan, kudomsrg@tmd.ac.jp.AbstractBACKGROUND: The aim of this study was to identify factors related to the recurrence of non-B or non-C (NBNC) hepatocellular carcinoma (HCC).
Journal of gastroenterology.J Gastroenterol.2013 Oct 18. [Epub ahead of print]
BACKGROUND: The aim of this study was to identify factors related to the recurrence of non-B or non-C (NBNC) hepatocellular carcinoma (HCC).STUDY DESIGN: Between April 2000 and March 2012, out of 621 consecutive HCC patients at our institution, 543 who underwent initial hepatectomy and had no extrah
PMID 24136219

Japanese Journal

非B非C型肝癌の特徴とSVR肝癌との類似点に関する解析 (特集非B非C型肝癌の現状と問題点)

田守昭博,岩井秀司,河田則文
消化器内科 53(4), 434-439, 2011-10
NAID 40019075031

Investigation of different methods, particularly percutaneous ablation therapy, for treating non-B, non-C hepatocellular carcinoma

Kioka Kiyohide,Kawasaki Yasuko,Nakai Takashi,Ishida Yumi,Maruyama Hirotsugu,Hiramatsu Shinsuke,Mori Aroka,Suekane Takehisa,Yamasaki Tomoaki,Sano Koji,Shiba Masatsugu,Nebiki Hiroko,Sato Hiroshi,Shimizu Sadatoshi,Kanazawa Akishige,Tsukamoto Tadashi
Journal of Microwave Surgery 29(0), 99-104, 2011
… The incidence of non-B, non-C hepatocellular carcinoma has shown an increasing trend in the recent years. … Therefore, we investigate the treatment methods for non-B, non-C hepatocellular carcinoma, particularly, the outcome of percutaneous ablation therapy. …
NAID 130001157668